DEFA14A ·Filed Apr 17, 2026

SMMT

Summit Therapeutics Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001599298-26-000033
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard annual filing with no immediate trading implications. Traders should monitor for any unexpected developments during the actual shareholder meeting, such as unexpected director changes or shareholder activism, but none are indicated in this filing.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
SMMT ▼ -40.01% at T+60d
NEUTRAL call ✗ call lost -40.01% · α vs SPY -46.79% · entry $25.12 → $15.07
Entry anchored
Apr 17, 03:59 PM ET
via exchange tick
T+1d
+5.02%
call +5.02% · α +5.67%
$26.38
settled 6mo ago
T+5d
-11.94%
call -11.94% · α -12.86%
$22.12
settled 5mo ago
T+20d
-36.23%
call -36.23% · α -40.43%
$16.02
settled 5mo ago
T+60d
-40.01%
call -40.01% · α -46.79%
$15.07
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Summit Therapeutics Inc. has filed a definitive proxy statement (DEFA14A) for its upcoming annual shareholder meeting. The filing is routine and contains standard information about the meeting, including the date, agenda items such as director elections and executive compensation, and voting procedures. No activist campaign or contentious shareholder proposals are indicated.

Key Facts

  • Company: Summit Therapeutics Inc. (SMMT)
  • Form Type: DEFA14A (Definitive Proxy Statement)
  • Filing Type: Routine annual proxy statement
  • Key Items: Director election, executive compensation, auditor ratification
  • No activist involvement or special proposals mentioned

Financial Impact

No immediate financial impact from this filing

Risk Factors

  • Potential for unexpected shareholder activism during the meeting
  • Possible director or executive compensation changes announced at the meeting

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001599298-26-000033
Document: 0001599298-26-000033-index-headers.html0001599298-26-000033
Document: 0001599298-26-000033-index.html0001599298-26-000033
Document: 0001599298-26-000033.txt0001599298-26-000033
16 reports for SMMT
Performance horizon
73% Hit rate 8 of 11 directional calls best @ T+60▲ +23.34%Jun 12, 2026
Filters
Rows
Reports for SMMT — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
BULLISH ★ 7/10
$17.40 $17.85▲ +2.59%▲ +1.77%$16.75 (−3.71%)
Sep 14, 2026
18d ago
8-K
BULLISH ★ 7/10
$18.42 $16.90▼ −8.25%▼ −8.36%$16.75 (−9.04%)
Sep 3, 2026
29d ago
8-K
BULLISH ★ 6/10
$17.13 $17.55▲ +2.45%▲ +3.60%$16.75 (−2.19%)
Aug 26, 2026
5w ago
8-K
BULLISH ★ 7/10
$14.23 $14.60▲ +2.60%▲ +2.72%$16.75 (+17.74%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$13.53 $15.10▲ +11.60%▲ +11.25%$16.75 (+23.84%)
Jul 22, 2026
10w ago
8-K
BULLISH ★ 7/10
$14.74 $12.80▼ −13.16%▼ −10.76%$16.75 (+13.67%)
Jun 12, 2026
16w ago
Insider Cluster
BULLISH ★ 6/10
$14.01 $13.75▼ −1.86%▼ −2.53%$16.75 (+19.59%)
Jun 12, 2026
16w ago
Institutional Cluster
MIXED ★ 4/10
$14.01 $13.75▼ −1.86%▼ −2.53%$16.75 (+19.59%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 3/10
$13.08 $14.07▲ +7.57%▲ +7.14%$16.75 (+28.10%)
Jun 9, 2026
16w ago
S-3ASR
BEARISH ★ 7/10
$13.05 $13.88▼ −6.36%▼ −2.93%$16.75 (−28.39%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (37h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access